Safety, Reactogenicity, and Immunogenicity of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine: a Single-blind and Randomized Study
Latest Information Update: 07 Nov 2023
At a glance
- Drugs Elasomeran (Primary) ; MVC COV1901 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 18 Jan 2022 Status changed from recruiting to active, no longer recruiting.
- 06 Dec 2021 Status changed from not yet recruiting to recruiting.
- 29 Nov 2021 New trial record